Y. Nakamura

ORCID: 0000-0003-4829-1604
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Biology and Fertility
  • Tracheal and airway disorders
  • Ovarian function and disorders
  • Adipokines, Inflammation, and Metabolic Diseases
  • Reproductive Health and Technologies
  • Congenital Heart Disease Studies
  • Hormonal Regulation and Hypertension
  • Cardiac Ischemia and Reperfusion
  • Toxic Organic Pollutants Impact
  • Virus-based gene therapy research
  • Multiple Sclerosis Research Studies
  • Pain Management and Opioid Use
  • Anesthesia and Neurotoxicity Research
  • Genomics, phytochemicals, and oxidative stress
  • Mycobacterium research and diagnosis
  • Lipid metabolism and disorders
  • Cancer Research and Treatments
  • Long-Term Effects of COVID-19
  • Pharmacovigilance and Adverse Drug Reactions
  • Adrenal and Paraganglionic Tumors
  • Vitamin K Research Studies
  • Seaweed-derived Bioactive Compounds
  • Medicinal Plant Pharmacodynamics Research
  • Hypothalamic control of reproductive hormones
  • Heat shock proteins research

Kyushu University
1987-2019

Nagasaki University
2004-2012

Waseda University
2011

Fukuoka Children's Hospital and Medical Center for Infectious Diseases
1991

The cervical and thoracic cross-sectional spinal cord area (CS-SCA) in multiple sclerosis (MS) correlates with disability, whilst such a correlation remains to be established neuromyelitis optica spectrum disorder (NMOSD). Our aim was clarify differences between MS NMOSD segments where CS-SCA is associated disability.The at C2/C3, C3/C4, T8/T9 T9/T10 vertebral disc levels measured 140 patients (111 relapsing-remitting 29 progressive MS) 42 anti-aquaporin-4 immunoglobulin G. Disability...

10.1111/ene.14038 article EN European Journal of Neurology 2019-07-15

3021 Background: CALGB 40101 is an ongoing phase III trial comparing the efficacy of standard therapy cyclophosphamide and doxorubicin (AC × 4 or 6 cycles) with single-agent paclitaxel (P as adjuvant for breast cancer in women 0-3 positive axillary lymph nodes. AC P are associated significant toxicities, peripheral neuropathy being major toxicity P. As part this study, we have collected germline DNA a pharmacogenetic GWAS to identify genetic predictors toxicity. Methods: Germline was...

10.1200/jco.2010.28.15_suppl.3021 article EN Journal of Clinical Oncology 2010-05-20

Physical activity-induced lowering of postprandial lipaemia is short-lived. However, little known regarding the role physical activity status on lipaemia. The purpose present study was to compare triacylglycerol concentrations in active and inactive older adults. A total 26 adults (aged 69.8±0.9 years, mean±SEM; 10 male 16 female) were analysed a cross-sectional design. Based accelerometer data, participants divided into either group (≥150 min/week moderate-intensity activity, N=15) or (<150...

10.1055/s-0031-1279770 article EN International Journal of Sports Medicine 2011-09-29

Autoantibodies against heat shock protein 40 (HSP40) and their clinical significance in ulcerative colitis (UC) have not been evaluated before. Twenty-six tissue specimens of inflamed areas from patients with UC, 16 Crohn's disease (CD) endoscopically normal tissues were analysed for HSP40 expression. Sera 47 UC 44 healthy volunteers examined the presence autoantibodies by enzyme-linked immunosorbent assay test. Immunohistochemistry showed that 17 out 26 patients, one specimen a CD patient...

10.1177/147323000403200206 article EN Journal of International Medical Research 2004-04-01

e13013 Background: Cancer chemotherapy has risk of severe infection due to neutropenia. Indication antibiotics tends expand. Meanwhile, abuse encourages the growth organisms resistant. This study was undertaken analyze fever during cancer reduce unnecessary uses antibiotics. Methods: Retrospectively, 1,016 cycles patients who have treated with in Division Respiratory Diseases, Kawasaki Medical School and Nagasaki Municipal Hospital were analyzed. The temperature equal or more than 37.5...

10.1200/jco.2011.29.15_suppl.e13013 article EN Journal of Clinical Oncology 2011-05-20

10.1016/j.jval.2015.03.1648 article EN publisher-specific-oa Value in Health 2015-05-01
Coming Soon ...